From Onivyde To OTx: Ipsen Fortifies Oncology with Primary Care Dealmaking

Ipsen's cash-generating primary care business is supporting a flurry of activity in its larger specialty care franchise. The French pharma has just signed a new deal with Italian company Akkadeas Pharma to give it a boost in primary care.